NCT06162507View on ClinicalTrials.gov

Study of CM310 in Children Subjects With Moderate-to-severe Atopic Dermatis

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

December 22, 2023

Primary Completion Date

July 4, 2024

Study Completion Date

July 4, 2024

Conditions
Atopic Dermatitis
Interventions
BIOLOGICAL

CM310

CM310 injection

Trial Locations (1)

Unknown

Beijing Children's Hospital Capital Medical University, Beijing

Sponsors
All Listed Sponsors
lead

Keymed Biosciences Co.Ltd

INDUSTRY

NCT06162507 - Study of CM310 in Children Subjects With Moderate-to-severe Atopic Dermatis | Biotech Hunter | Biotech Hunter